Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydrocortisone versus caffeine for postdural puncture headache
PACTR201708002484171Completed
- Start
- Nov 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in post-dural puncture headache (PDPH) comparing Hydrocortisone with Caffeine (2 arms). Primary endpoint: Comparison of hydrocortisone versus caffeine in treatment of postdural puncture headache within 48 hours. Started Nov 2016; status: completed.
02
Drugs
hydrocortisonecaffeine
03
Conditions
post-dural puncture headache (PDPH)
Beyond the preview
Go deeper on PACTR201708002484171.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201708002484171.